NAD+ vs NADH: Identity, Measurement and Stability Guide
The plus sign is not decorative: NAD+ is the oxidized form and NADH is the reduced form. Their formulas, spectra, redox behavior…
Read source review →
Research Topic
Longevity & Cellular Aging
Topic knowledge
Source-reviewed reading for longevity & cellular aging
Continue from catalog navigation into editorial analysis, evidence records and quality-documentation guidance.
Showing 7–10 of 10 reviewed articles · Page 2 of 2
NAD+ Homeostasis Evidence Map: From Cell Biology to Human Claims
NAD+ is both a redox cofactor and a consumed substrate for signaling enzymes. That broad biology is well established, but it does…
Read source review →SS-31, Elamipretide and Forzinity: Why the Finished-Drug Distinction Matters
SS-31 and elamipretide are names used around the same mitochondrial-targeted peptide, but Forzinity is a specific FDA-approved finished drug with an approved…
Read source review →Elamipretide in Barth Syndrome: What the 12-Patient Trial and FDA Record Show
Elamipretide now has an FDA-approved finished product for a narrow Barth syndrome indication, but the approval rests on an unusual rare-disease dataset.…
Read source review →Need a peptide for longevity & cellular aging research?
If a target is not listed, submit the sequence, scale and specification for a custom-project feasibility review.